Patients and clinicians are united in a vision for the future; low trust in AI, interoperability, burnout, and care accessibility top the list of c...
Over the past several years, management has initiated discussions with potential strategic collaborators to provide the resources to advance PRP into clini...
Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio High potency ionizable li...
Calder Biosciences Inc., a molecular engineering and clinical manufacturing-stage biotechnology company pioneering its 3D-Vaxlockä platform techn...
PathomIQ is a leading provider of AI-enabled tools for prostate, breast, lung and other cancers that enable precision medicine by extracting yet untapped i...
Application is supported by data from the Phase 3 CARTITUDE-4 study, which showed significant improvement in primary endpoint of progre...
Researchers led by Cathleen Lutz, Ph.D., are using an exciting new method, preclinical genomic editing, to develop safe, effective therapies for rare disea...
As the first facility of Samsung Biologics’ second Bio Campus at its headquarters in Songdo, South Korea, Plant 5 is expected to have the shortest co...
Sonic DLi is a deep learning (DL) technology that acquires high-quality magnetic resonance (MR) images up to 12 timesii faster than conventional methods,...
Agilent Technologies Inc. (NYSE: A) announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, b...
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intellige...
The newly introduced ZEISS Volutome is an in-chamber ultramicrotome for ZEISS field emission scanning electron microscopes (FE-SEM). It is designed to imag...
Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilent Bio...
Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection...
© 2025 Biopharma Boardroom. All Rights Reserved.
